Watch our session as we sit down with Dr. Michael Bookman and Dr. Debra Richardson of NOCC's Medical and Scientific Advisory Board to grasp the year's advancements in ovarian cancer - from risk guidelines to PARP inhibitor evolution and Antibody-Drug Conjugates (ADCs) and more. Empower yourself with knowledge!
Presenter: Dr. Michael Bookman, Director of Gynecologic Oncology Therapeutics - Kaiser Permanente Northern California, NOCC Medical and Scientific Advisory Board member.
Presenter: Dr. Debra Richardson, Associate Professor, Gynecologic Oncology, University of Oklahoma Health Sciences Center, NOCC Medical and Scientific Advisory Board member.
--------
About the National Ovarian Cancer Coalition (NOCC):
Since 1991, the National Ovarian Cancer Coalition (NOCC) has been a dedicated advocate and support system for ovarian cancer survivors, caregivers, and their families. We have provided support to thousands of survivors, delivered millions of educational resources, and partnered with local communities nationwide to raise awareness about ovarian cancer.
It is our mission to save lives through the prevention and cure of ovarian cancer and to improve the quality of life for survivors and their caregivers. With this commitment, we reach out to all touched by this disease to offer support, services, information, and, most of all, hope.
For more information, please visit ovarian.org or call 888-OVARIAN (888-682-7426).
Негізгі бет Hope on The Horizon
Пікірлер